Keith A. Betts
Impact in
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
- Dermatology top 2%
- Dermatology and Skin Diseases
Papers in
- Hematology 21
- Autoimmune and Inflammatory Disorders Research 13
- Rheumatology 27
- Rheumatoid Arthritis Research and Therapies 19
- Systemic Lupus Erythematosus Research 9
- Co-authors
- Eric Q. WuJames SignorovitchAvani JoshiApril W. ArmstrongPaul HodgkinsJipan XieVanja SikiricaM. Haim Erder
- Journals
- Value in Health (9 papers)Advances in Therapy (9 papers)Current Medical Research and Opinion (8 papers)Journal of Clinical Oncology (7 papers)Rheumatology and Therapy (5 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Keith A. Betts
119 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 113
- Hematology 326
- Dermatology 251
- Immunology 582
- Rheumatology 366
- Pulmonary and Respiratory Medicine 437
Countries citing papers authored by Keith A. Betts
This map shows the geographic impact of Keith A. Betts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith A. Betts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith A. Betts more than expected).
Fields of papers citing papers by Keith A. Betts
This network shows the impact of papers produced by Keith A. Betts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith A. Betts. The network helps show where Keith A. Betts may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keith A. Betts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 16 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 88 | |
| 15 | 2020 | 6 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 16 | |
| 18 | Effect of adalimumab on visual functioning (VFQ-25) in VISUAL-1 trial patients with non-anterior non-infectious uveitis | 2015 | 2 |
| 19 | 2009 | 5 | |
| 20 | 2009 | 6 |
About Keith A. Betts
Keith A. Betts is a scholar working on Hematology, Rheumatology, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 129 papers that have together received 2.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (19 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers), Cancer Immunotherapy and Biomarkers (17 papers), Psoriasis: Treatment and Pathogenesis (15 papers), Autoimmune and Inflammatory Disorders Research (13 papers), Potassium and Related Disorders (12 papers), Economic and Financial Impacts of Cancer (10 papers) and Systemic Lupus Erythematosus Research (9 papers). The work is most often cited by research in Hematology (326 citations), Dermatology (251 citations), Immunology (582 citations), Rheumatology (366 citations) and Pulmonary and Respiratory Medicine (437 citations). Keith A. Betts has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Eric Q. Wu, James Signorovitch, Avani Joshi, April W. Armstrong, Paul Hodgkins, Jipan Xie, Vanja Sikirica, M. Haim Erder, Mei Lü and Fan Mu. Their work appears in journals such as Value in Health, Advances in Therapy, Current Medical Research and Opinion, Journal of Clinical Oncology and Rheumatology and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.